Cowen & Company Initiates Adaptimmune Therapeutics With Outperform
June 01, 2015 at 08:44 AM EDT
Analysts at Cowen & Company initiated coverage on Adaptimmune Therapeutics PLC – ADR (NASDAQ: ADAP) with a Outperform ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.